Compounded Semaglutide Price in 2026: What You'll Actually Pay Per Month

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Compounded semaglutide costs $179 to $499 per month across major telehealth platforms in 2026, compared to $940+ for brand-name Ozempic without insurance
• Local 503A compounding pharmacies charge $150 to $350 per month but require an in-person provider relationship
• Price includes medication, supplies, provider visits, and shipping for most telehealth platforms
• Compounded semaglutide is not covered by insurance and cannot be purchased with HSA/FSA funds at most providers

Direct answer (40-60 words)

Compounded semaglutide costs $179 to $499 per month in 2026, depending on the provider, dosage tier, and whether the price includes clinical visits. FormBlends charges $179 to $279 monthly. Local compounding pharmacies range from $150 to $350 but require a separate provider relationship. No insurance accepts compounded semaglutide for coverage.

Table of contents

1. The 30-second pricing breakdown
2. What "compounded semaglutide" actually means
3. Telehealth platform pricing comparison (2026)
4. Local 503A compounding pharmacy costs
5. What's included in the monthly price
6. Dosage tiers and how they affect cost
7. The four hidden costs most platforms don't advertise
8. Brand-name semaglutide cost comparison
9. Why insurance doesn't cover compounded semaglutide
10. The FormBlends Pricing Transparency Framework
11. When compounded semaglutide costs more than you expect
12. How to verify total cost before your first order
13. FAQ

The 30-second pricing breakdown

As of Q1 2026, here's what compounded semaglutide costs across the most common purchase channels:

Telehealth platforms (all-inclusive): $179 to $499/month

• FormBlends: $179 to $279
• Major competitor platforms: $199 to $499
• Includes medication, syringes, alcohol pads, provider visits, shipping

Local 503A compounding pharmacies: $150 to $350/month

• Medication only (no provider visits, no supplies)
• Requires existing provider relationship
• Pickup or local delivery in most cases

503B outsourcing facilities: $180 to $320/month

• Bulk-compounded, shipped to provider offices
• Patient pays provider's markup (varies widely)
• Less common for individual patients

Brand-name alternatives for comparison:

• Ozempic (semaglutide): $940 to $1,150/month cash price
• Wegovy (semaglutide): $1,350 to $1,450/month cash price
• With insurance and savings card: $25 to $500/month (varies dramatically)

The price difference between compounded and brand-name is the primary reason patients choose compounded semaglutide. For uninsured patients or those with high copays, compounded represents a 70-85% cost reduction.

What "compounded semaglutide" actually means

Compounded semaglutide is not a generic version of Ozempic. It's a custom-prepared medication made by a licensed compounding pharmacy using the same active pharmaceutical ingredient (semaglutide base) that Novo Nordisk uses in Ozempic and Wegovy.

Three types of compounding pharmacies prepare semaglutide:

503A pharmacies compound medications in response to individual patient prescriptions. They're state-licensed and regulated by state pharmacy boards. Most local compounding pharmacies fall into this category. They prepare your specific prescription after your provider sends it.

503B outsourcing facilities compound medications in larger batches under FDA oversight. They can ship across state lines without patient-specific prescriptions. They typically sell to provider offices, which then dispense to patients.

Hospital-based compounding occurs in hospital pharmacies for inpatient use. Not accessible to outpatient weight-loss patients.

When you order from a telehealth platform like FormBlends, the medication comes from either a 503A or 503B partner pharmacy. The platform handles provider matching, prescription writing, and pharmacy coordination. You receive a vial of compounded semaglutide with syringes and instructions.

The medication is chemically identical to brand-name semaglutide but prepared in a different form factor (vial instead of pre-filled pen) and without FDA approval for the finished product.

Telehealth platform pricing comparison (2026)

Platform	Monthly cost range	What's included	Initial consultation fee	Dosage flexibility
FormBlends	$179 to $279	Medication, supplies, provider visits, shipping	$0 (included)	0.25 mg to 2.4 mg+
Platform A	$297 to $399	Medication, supplies, quarterly visits	$49 initial visit	0.25 mg to 2 mg
Platform B	$199 to $499	Medication, supplies, monthly check-ins	$0 (included)	0.5 mg to 2.4 mg
Platform C	$249 to $375	Medication, supplies, biweekly coaching	$99 initial visit	1 mg to 2 mg only
Platform D	$329 flat rate	Medication, supplies, app access	$0 (included)	0.5 mg to 1.7 mg

Pricing as of Q1 2026. Platforms update pricing quarterly. Most platforms charge more for higher doses (1.7 mg+ weekly).

What most articles get wrong: Many comparison articles list the lowest advertised price without noting that it applies only to the starter dose (0.25 mg). The maintenance dose (1.7 mg to 2.4 mg weekly) costs 30-50% more at most platforms. A patient who starts at $199/month often pays $299/month by month four.

FormBlends uses a two-tier pricing model: $179/month for doses up to 1 mg weekly, $279/month for doses above 1 mg. This structure eliminates surprise price increases during titration.

Local 503A compounding pharmacy costs

If you have an existing relationship with a provider who prescribes weight-loss medications, you can fill compounded semaglutide at a local 503A compounding pharmacy.

Typical pricing structure:

• Medication (10 mg vial, 4-8 week supply): $150 to $350
• Syringes (box of 100 U-100 insulin syringes): $15 to $30
• Alcohol prep pads (box of 100): $5 to $10
• Sharps container: $8 to $15
• Provider visit (separate): $75 to $200 per visit

Total first-month cost: $250 to $600 (including provider visit and supplies). Subsequent months: $150 to $350 (medication only, assuming you have leftover supplies).

Geographic variation: Compounding pharmacy pricing varies significantly by region. Urban areas with multiple compounding pharmacies (Los Angeles, Miami, Dallas, Phoenix) have lower prices ($150 to $220/vial) due to competition. Rural areas with one local compounder charge $280 to $350/vial.

The coordination cost: Local compounding requires you to manage three separate relationships (provider for prescription, pharmacy for medication, supplier for syringes if pharmacy doesn't stock them). Telehealth platforms bundle all three, which justifies the 20-40% price premium over local compounding.

What's included in the monthly price

Telehealth platforms advertise "all-inclusive" pricing, but the definition of "all-inclusive" varies.

Standard inclusions (95% of platforms):

• Compounded semaglutide vial (dose-appropriate volume)
• U-100 insulin syringes (typically 8-12 per month)
• Alcohol prep pads
• Shipping to your address
• Access to provider messaging

Common inclusions (60-70% of platforms):

• Initial medical consultation
• Follow-up visits (monthly or quarterly)
• Dosage adjustments without additional fees
• Sharps disposal container

Rare inclusions (20-30% of platforms):

• Nutrition coaching or dietitian access
• Fitness app integration
• Lab work coordination (though labs themselves cost extra)
• Anti-nausea medication if needed

Never included:

• Insurance reimbursement (compounded semaglutide is not covered)
• Lab work costs (lipid panel, A1C, metabolic panel typically $80 to $200 if ordered)
• Additional medications for side effects beyond the first month
• Refrigerated shipping (most compounded semaglutide ships at room temperature, stable for 7-10 days in transit)

FormBlends includes medication, syringes, alcohol pads, sharps container, initial visit, and unlimited provider messaging in the base price. Labs are ordered through patient's existing provider or a third-party lab service at separate cost.

Dosage tiers and how they affect cost

Semaglutide dosing follows a standard titration schedule that starts low and increases monthly:

Standard titration path:

• Month 1: 0.25 mg weekly
• Month 2: 0.5 mg weekly
• Month 3: 1 mg weekly
• Month 4: 1.7 mg weekly
• Month 5+: 2.4 mg weekly (maintenance)

Most platforms price by dosage tier:

Tier 1 (starter doses: 0.25 mg to 0.5 mg): $179 to $249/month Tier 2 (mid doses: 1 mg to 1.7 mg): $229 to $349/month Tier 3 (maintenance: 2.4 mg+): $279 to $499/month

The total cost over six months (typical time to reach maintenance dose):

Platform pricing model	6-month total cost
Flat rate ($329/month all doses)	$1,974
Two-tier (FormBlends model)	$1,553 ($179 × 3 + $279 × 3)
Three-tier (common competitor model)	$1,734 ($199 × 1 + $249 × 2 + $349 × 3)
Four-tier (premium platforms)	$2,145 ($199 × 1 + $299 × 2 + $399 × 3)

Patients who compare only the advertised starting price miss the 6-month total, which varies by $400 to $600 between platforms.

The four hidden costs most platforms don't advertise

Hidden cost 1: The consultation fee resurrection. Some platforms advertise "$0 consultation fee" but charge a "reactivation fee" ($49 to $99) if you pause treatment and restart later. This fee is buried in terms of service. If you stop for two months due to side effects and restart, you pay the fee again.

Hidden cost 2: Dosage adjustment fees. A small number of platforms charge $25 to $50 for "unscheduled dosage adjustments" (changing your dose outside the standard titration schedule). If you need to drop from 1 mg back to 0.5 mg due to nausea, some platforms charge for the provider time to authorize the change.

Hidden cost 3: Expedited shipping. Standard shipping is included. Expedited shipping (2-day or overnight) costs $25 to $75 extra. If you're traveling and need your medication earlier than the standard 5-7 day window, you pay for speed.

Hidden cost 4: State-specific telehealth fees. A few states (Texas, California, New York as of 2026) require an additional provider licensing verification fee for telehealth prescriptions. This fee ($15 to $40) appears at checkout for patients in those states and isn't mentioned in the advertised price.

FormBlends discloses all fees upfront in the cost estimator before account creation. The price you see at signup is the price you pay, with no reactivation fees or dosage adjustment charges.

Brand-name semaglutide cost comparison

To understand whether compounded semaglutide is cheaper for your situation, compare against brand-name options:

Ozempic (FDA-approved for type 2 diabetes, used off-label for weight loss):

• Cash price: $940 to $1,150/month
• With commercial insurance (average): $150 to $300/month
• With insurance + Novo Nordisk savings card: $25 to $150/month
• With Medicare Part D: $200 to $500/month (no savings card)
• Uninsured with GoodRx: $850 to $1,000/month

Wegovy (FDA-approved for weight loss):

• Cash price: $1,350 to $1,450/month
• With commercial insurance (average): $200 to $400/month
• With insurance + savings card: $25 to $200/month
• Medicare doesn't cover Wegovy for weight loss
• Uninsured with GoodRx: $1,200 to $1,350/month

When brand-name is cheaper:

• Your insurance copay with savings card is under $100/month
• You qualify for Novo Nordisk's patient assistance program (free medication for low-income patients)
• Your employer covers weight-loss medications with low copays

When compounded is cheaper:

• You're uninsured
• Your insurance doesn't cover semaglutide for weight loss
• Your copay is over $200/month
• You're on Medicare (which doesn't cover weight-loss medications and excludes you from savings cards)

For a detailed comparison of Ozempic insurance costs, see our guide on Ozempic cost at Walmart with insurance.

Why insurance doesn't cover compounded semaglutide

Insurance plans (commercial, Medicare, Medicaid) don't cover compounded medications except in rare cases where the FDA-approved version is unavailable or the patient has a documented allergy to an inactive ingredient.

The regulatory reason: Compounded medications are not FDA-approved. Insurance formularies include only FDA-approved drugs. Compounded semaglutide doesn't have an NDC (National Drug Code), which is required for insurance billing.

The policy reason: If insurance covered compounded versions of expensive brand-name drugs, patients would always choose the cheaper compounded option, undermining the pharmacy benefit manager's negotiated rebates with manufacturers.

The exception: During the 2023-2024 semaglutide shortage, some insurance plans temporarily covered compounded semaglutide when brand-name was unavailable. As of 2026, with Ozempic and Wegovy back in consistent supply, this exception has ended at most plans.

HSA and FSA: Most HSA/FSA administrators don't reimburse compounded semaglutide because it's not FDA-approved. A few administrators allow it if you submit a letter of medical necessity from your provider. Check with your specific HSA/FSA plan before assuming reimbursement.

Patients pay out-of-pocket for compounded semaglutide. This is the trade-off for the 70-85% cost reduction compared to brand-name cash prices.

The FormBlends Pricing Transparency Framework

Most telehealth platforms bury the total cost across multiple pages. We built a four-question framework to surface the real price before signup.

Question 1: What's the all-in monthly cost at maintenance dose? Don't compare starter-dose prices. Compare the price you'll pay in month 5 when you're at 2.4 mg weekly. That's your steady-state cost.

Question 2: What fees apply if I pause or adjust? Ask explicitly: "If I need to pause for a month due to side effects, do I pay a reactivation fee?" and "If I need to lower my dose, is there a fee?"

Question 3: What's the 6-month total cost? Add up months 1 through 6 using the platform's actual tier pricing. This number varies by $400+ between platforms advertising similar starting prices.

Question 4: What's included vs. what costs extra? Make a checklist: initial visit, follow-up visits, syringes, sharps container, shipping, dosage adjustments, provider messaging. If something isn't explicitly listed as included, assume it costs extra.

[Diagram suggestion: Decision tree flowchart. Start: "Do you have insurance?" If yes: "Does insurance cover semaglutide for weight loss with copay under $150?" If yes: "Brand-name likely cheaper." If no: "What's your copay?" branches to compounded if over $200. If no insurance: "Compounded is 70-85% cheaper than brand cash price."]

This framework eliminates the most common cost surprise: discovering in month 4 that your price just increased by $100/month.

When compounded semaglutide costs more than you expect

Scenario 1: You need a higher-than-standard dose. Some patients require 3 mg or 4 mg weekly for effective weight loss, above the standard 2.4 mg Wegovy dose. Compounded pharmacies can prepare higher doses, but most platforms charge $100 to $150 extra per month for doses above 2.4 mg.

Scenario 2: You're a high-volume patient (over 250 lbs starting weight). Larger patients sometimes need higher doses sooner in the titration schedule. If you jump from 0.5 mg to 1.7 mg in month 2 instead of month 4, you hit the higher pricing tier earlier, increasing your 6-month total.

Scenario 3: You need combination therapy. Some providers prescribe semaglutide + metformin or semaglutide + phentermine for patients with insulin resistance or slow response. The additional medication costs $30 to $80/month extra.

Scenario 4: You require specialized compounding (preservative-free, alternative buffer). Standard compounded semaglutide includes benzyl alcohol as a preservative. Patients with benzyl alcohol sensitivity need preservative-free compounding, which costs $50 to $100 more per vial due to shorter shelf life and smaller batch sizes.

Scenario 5: Your state requires additional provider oversight. A few states (New York, California as of 2026 regulations) require monthly provider check-ins for GLP-1 prescriptions, even if the patient is stable. If your platform normally includes quarterly visits, the monthly visit requirement can add $40 to $60/month in provider fees.

FormBlends flags these scenarios during intake and provides upfront cost estimates for patients who fit them.

How to verify total cost before your first order

Step 1: Use the platform's cost calculator. Most telehealth platforms have a "pricing" or "cost estimator" page. Enter your target maintenance dose (usually 2.4 mg weekly) and calculate the monthly cost at that dose, not the starter dose.

Step 2: Ask for a 6-month cost breakdown in writing. Email or chat with the platform: "Can you provide a month-by-month cost breakdown for months 1 through 6, assuming standard titration?" Legitimate platforms provide this in under 24 hours.

Step 3: Check the terms of service for fee language. Search the terms for "reactivation," "adjustment," "pause," and "expedited." If any of these trigger fees, they'll be mentioned in the terms.

Step 4: Verify what's included. Ask: "Does the monthly price include syringes, alcohol pads, sharps container, and shipping?" If the answer is vague, ask for a specific list.

Step 5: Confirm refund and cancellation policy. Ask: "If I cancel after one month, do I get a prorated refund?" and "Is there a cancellation fee?" Most platforms allow cancellation anytime but don't refund the current month.

This 5-step verification, completed before creating an account, prevents the most common complaint in compounded semaglutide telehealth: "I thought it was $199/month but I'm paying $349."

FormBlends clinical pattern: The dose-price mismatch

Across our patient data (pattern recognition from clinical workflows, not published stats), we see a consistent mismatch between the dose patients expect to stay on and the dose they actually maintain.

The pattern: About 60% of patients assume they'll stay at 1 mg or 1.7 mg weekly because that's where they feel good and see results. They budget for mid-tier pricing. By month 6, about 40% of that group has titrated to 2.4 mg because weight loss plateaued at the lower dose.

The cost implication: Patients who budget $229/month (mid-tier) discover they need $279/month (high-tier) to continue losing weight. The $50/month difference over 6 months is $300, which matters for patients on tight budgets.

The solution: We recommend patients budget for maintenance-dose pricing from month 1, even if they're starting at 0.25 mg. If they stay at a lower dose, they've overestimated and have extra budget. If they titrate to 2.4 mg (which most do), they've budgeted correctly.

This pattern explains why platforms with flat-rate pricing (one price for all doses) have higher patient retention. The price is predictable. Patients don't face a "pay more or stop losing weight" decision in month 5.

When you should NOT choose compounded semaglutide based on price alone

Situation 1: Your insurance copay is under $75/month. If you have commercial insurance, your plan covers semaglutide, and your copay with the Novo Nordisk savings card is $25 to $75/month, brand-name Ozempic or Wegovy is cheaper than compounded. The $25 savings card price is the lowest legal price for semaglutide in the U.S. Compounded can't beat it.

Situation 2: You qualify for patient assistance. Novo Nordisk's patient assistance program provides free Ozempic or Wegovy to patients with income below 400% of the federal poverty level (about $60,000 for an individual). Free is cheaper than $179/month.

Situation 3: You strongly prefer FDA-approved medications. Some patients are uncomfortable with non-FDA-approved compounded medications, even at significant cost savings. If medication approval status is a priority for you, the price difference doesn't outweigh the preference for FDA oversight.

Situation 4: You want the pen injector convenience. Brand-name Ozempic and Wegovy come in pre-filled pens. You twist the dial, inject, dispose. Compounded semaglutide requires drawing from a vial with a syringe, which some patients find inconvenient or anxiety-inducing. If the pen format is worth $700/month to you, choose brand-name.

Situation 5: Your provider doesn't support compounded medications. Some endocrinologists and bariatric specialists don't prescribe or monitor compounded medications due to liability concerns or practice policy. If your existing provider relationship is important and they won't support compounded semaglutide, the cost savings may not justify switching providers.

This is the steelman against compounded semaglutide. Price is not the only decision variable. For some patients, brand-name is the better choice even at 5x the cost.

FAQ

How much does compounded semaglutide cost per month? Compounded semaglutide costs $179 to $499 per month depending on the provider and dosage tier. FormBlends charges $179/month for doses up to 1 mg weekly and $279/month for doses above 1 mg. Local compounding pharmacies charge $150 to $350 for medication only.

Is compounded semaglutide cheaper than Ozempic? Yes, for uninsured patients. Compounded semaglutide costs $179 to $499/month compared to Ozempic's $940 to $1,150/month cash price. For insured patients with low copays (under $100/month), brand-name Ozempic may be cheaper.

Does insurance cover compounded semaglutide? No. Insurance plans don't cover compounded medications because they're not FDA-approved. Patients pay out-of-pocket for compounded semaglutide. HSA/FSA reimbursement is rare and plan-specific.

What's included in the compounded semaglutide price? Most telehealth platforms include medication, syringes, alcohol pads, provider visits, and shipping in the monthly price. Some platforms charge extra for initial consultations, dosage adjustments, or expedited shipping. Verify inclusions before ordering.

Why do compounded semaglutide prices vary so much between providers? Pricing varies based on pharmacy sourcing costs, provider visit frequency, platform overhead, and profit margin. Telehealth platforms charge more than local pharmacies because they bundle provider services, but local pharmacies require you to find your own provider.

Can I use a GoodRx coupon for compounded semaglutide? No. GoodRx coupons apply only to FDA-approved medications filled at retail pharmacies. Compounded medications don't have NDC codes, which GoodRx requires for coupon processing.

How does compounded semaglutide pricing compare to Wegovy? Wegovy costs $1,350 to $1,450/month without insurance. Compounded semaglutide costs $179 to $499/month. Compounded is 65-85% cheaper than Wegovy's cash price. With insurance and savings card, Wegovy can cost as little as $25/month for eligible patients.

Do compounded semaglutide prices increase as dosage increases? At most platforms, yes. Starter doses (0.25 mg to 0.5 mg) cost $179 to $249/month. Maintenance doses (2.4 mg weekly) cost $279 to $499/month. FormBlends uses a two-tier model: $179 for doses up to 1 mg, $279 for doses above 1 mg.

What's the cheapest way to get compounded semaglutide? The cheapest option is a local 503A compounding pharmacy if you have a provider who will prescribe it. Medication-only cost is $150 to $250/month. Add $75 to $200 for provider visits. Total: $225 to $450/month, but requires managing multiple relationships.

Are there hidden fees with compounded semaglutide? Some platforms charge reactivation fees ($49 to $99) if you pause and restart, dosage adjustment fees ($25 to $50), or state-specific telehealth fees ($15 to $40). FormBlends doesn't charge reactivation or adjustment fees. Verify fee structure before ordering.

Can I get compounded semaglutide for less than $179/month? Rarely. A few local compounding pharmacies in competitive markets (Los Angeles, Miami, Phoenix) charge $150 to $180/month for medication only, but you pay separately for provider visits and supplies. All-inclusive pricing under $179/month is uncommon as of 2026.

How much does a 6-month supply of compounded semaglutide cost? Total 6-month cost ranges from $1,350 to $2,400 depending on the platform's pricing tiers. FormBlends 6-month total (standard titration) is approximately $1,553. Flat-rate platforms charge around $1,974. Compare 6-month totals, not monthly starting prices.

Sources

1. FDA. Compounded Drugs: Questions and Answers. Updated 2025.
2. National Association of Boards of Pharmacy. Survey of Compounding Pharmacy Pricing. 2025.
3. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021.
4. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
5. Novo Nordisk. Ozempic Prescribing Information. Revised 2024.
6. Novo Nordisk. Wegovy Prescribing Information. Revised 2024.
7. GoodRx Research Team. Semaglutide Pricing Analysis 2025-2026. Published January 2026.
8. American Society of Health-System Pharmacists. Drug Shortages Statistics. Updated March 2026.
9. Centers for Medicare & Medicaid Services. Medicare Part D Formulary Reference File. 2026.
10. National Community Pharmacists Association. Compounding Pharmacy Market Report. 2025.
11. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
12. Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.
13. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022.
14. Kushner RF et al. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity. 2020.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. GoodRx is a trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, GoodRx, or any other companies mentioned in this article.